Clinical trial
The Effect of On-site CT-derived Fractional Flow Reserve on the Management Making for the Patients With Stable Chest Pain (TARGET Trial)
NCT03901326 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of On-site CT-derived Fractional Flow Reserve on the Management Making for the Patients With Stable Chest Pain (TARGET Trial)
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 10, 2019
- Completion date
- October 31, 2022
- Enrollment
- 1,216 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.